| Breakdown | TTM | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 106.45M | 97.70M | 87.93M | 75.26M | 69.62M | 55.03M |
| Gross Profit | 28.25M | 25.47M | 22.83M | 19.57M | 18.40M | 14.26M |
| EBITDA | 11.60M | 13.36M | 11.89M | 9.20M | 9.34M | 6.35M |
| Net Income | 9.71M | 8.55M | 7.65M | 6.73M | 6.65M | 4.33M |
Balance Sheet | ||||||
| Total Assets | 43.92M | 45.70M | 41.30M | 37.88M | 37.40M | 33.26M |
| Cash, Cash Equivalents and Short-Term Investments | 6.51M | 9.69M | 8.37M | 9.15M | 10.48M | 7.37M |
| Total Debt | 1.92M | 2.16M | 2.37M | 648.03K | 1.11M | 1.55M |
| Total Liabilities | 27.14M | 25.33M | 24.36M | 20.02M | 18.52M | 16.67M |
| Stockholders Equity | 16.78M | 20.36M | 16.94M | 17.86M | 18.88M | 16.59M |
Cash Flow | ||||||
| Free Cash Flow | 7.17M | 5.47M | 7.46M | 7.17M | 8.27M | 5.45M |
| Operating Cash Flow | 7.97M | 6.24M | 7.53M | 7.23M | 8.31M | 5.50M |
| Investing Cash Flow | 241.67K | 1.19M | 1.46M | 157.73K | -32.35K | -11.79K |
| Financing Cash Flow | -11.59M | -6.12M | -9.78M | -8.72M | -5.17M | -2.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £144.15M | 9.55 | 52.26% | 5.98% | 16.29% | 22.80% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | £275.77M | -3.42 | -12.22% | 15.28% | -3.91% | -310.36% | |
60 Neutral | £144.60M | -138.94 | 1.15% | 2.75% | 8.01% | -23.02% | |
54 Neutral | £325.60M | 275.23 | 0.58% | 2.31% | 6.90% | 145.00% | |
41 Neutral | £320.29M | -2.81 | -142.88% | ― | -4.87% | ― |